Bharat Biotech’s Covaxin gets approval for the vaccination of 2-18 years:


On Tuesday, it was recommended by the expert panel for clinical trial, to those who were aged between 2 to 18 years old and this was provided for the production of Coronavirus vaccine by Bharat Biotech’s which is named as Covaxin. The trail will going to be placed at almost of 525 subjects at various sites, which including of AIIMS, Delhi, AIIMS Patna, and Medtronic Institute of Medical Science, Nagpur.
In Hyderabad, Bharat Biotech’s application was seeking a permission for conducting some trails for much security and for safety, reactogenicity and immunogenicity of Covaxin, to the children who were aged from the 2 to 18 years. The subject Expert Committee conducted a meeting on the present pandemic situation of corona virus of the Central Drugs Standard Control Organization which is deliberately recommends people to conduct for a clinical trial.

Earlier, On February 24 it was proposed in the Subject expert Committee meeting. As of now, the vaccination was only limited to the people who were at the age of above 18 years and presently by keeping an fear of covid 3rd wave of corona virus which mostly going to affect the children below 18 years. For that , it introduced Covaxin for the children between the age of 2 to 18 years old.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close